Extremely potent human monoclonal antibodies from COVID-19 convalescent patients

Human monoclonal antibodies are safe, preventive, and therapeutic tools that can be rapidly developed to help restore the massive health and economic disruption caused by the coronavirus disease 2019 (COVID-19) pandemic. By single-cell sorting 4,277 SARS-CoV-2 spike protein-specific memory B cells f...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cell
Asıl Yazarlar: Andreano, Emanuele, Nicastri, Emanuele, Paciello, Ida, Pileri, Piero, Manganaro, Noemi, Piccini, Giulia, Manenti, Alessandro, Pantano, Elisa, Kabanova, Anna, Troisi, Marco, Vacca, Fabiola, Cardamone, Dario, De Santi, Concetta, Torres, Jonathan L., Ozorowski, Gabriel, Benincasa, Linda, Jang, Hyesun, Di Genova, Cecilia, Depau, Lorenzo, Brunetti, Jlenia, Agrati, Chiara, Capobianchi, Maria Rosaria, Castilletti, Concetta, Emiliozzi, Arianna, Fabbiani, Massimiliano, Montagnani, Francesca, Bracci, Luisa, Sautto, Giuseppe, Ross, Ted M., Montomoli, Emanuele, Temperton, Nigel, Ward, Andrew B., Sala, Claudia, Ippolito, Giuseppe, Rappuoli, Rino
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier Inc. 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7901298/
https://ncbi.nlm.nih.gov/pubmed/33667349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cell.2021.02.035
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller